Patents/Assignees

CRITITECH, Inc.

10 patents in portfolio

US12390459utility2025
Methods for Solid Tumor Treatment
0 cites
US12329858utility2025
Local Delivery of Antineoplastic Particles in Combination with Systemic Delivery of Immunotherapeutic Agents for the Treatment of Cancer
0 cites
US12128131utility2024
Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
0 cites
US12029818utility2024
Lapatinib Particles and Uses Thereof
0 cites
US11931368utility2024
Glucocorticoid “nintedanib” Particles and Their Use
0 cites
US11918691utility2024
Local Delivery of Antineoplastic Particles in Combination with Systemic Delivery of Immunotherapeutic Agents for the Treatment of Cancer
0 cites
US11737972utility2023
Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
0 cites
US11738014utility2023
Niraparib Particles and Uses Thereof
0 cites
US11738029utility2023
Rucaparib Particles and Uses Thereof
0 cites
US11583499utility2023
Local Delivery of Antineoplastic Particles in Combination with Systemic Delivery of Immunotherapeutic Agents for the Treatment of Cancer
0 cites